[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351198-105":59,"doc-detail-351198-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mutational-signatures-in-hematological-malignancies","Mutational signatures in hematological malignancies","","Somatic mutations in human tumors reflect one or more underlying mutational processes, and each process leaves a distinct “signature” of mutation types. High-throughput DNA sequencing enables genome-wide profiling of mutation types, supporting inference methods that decompose the full mutation set into individual signatures. While many signatures have known etiologies, most studies have focused on solid tumors, leaving hematological cancers less characterized. This review summarizes the history, methods, challenges, and advances for hematologic malignancies, highlighting links from normal blood cells to malignant development and potential clinical value for diagnosis, prognosis, and treatment decisions.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mutational-signatures-in-hematological-malignancies/351198/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mutational-signatures-in-hematological-malignancies/351198.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-18","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What are mutational signatures and why are they important in cancer research?","Question",{"text":112,"@type":113},"Mutational signatures are recurring patterns of mutation types shaped by specific biological processes or exposures. They help connect a tumor’s mutational landscape to mechanisms underlying its evolution.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does high-throughput DNA sequencing support mutational signature inference?",{"text":117,"@type":113},"High-throughput sequencing enables comprehensive, genome-wide assessment of mutation types. This allows computational methods to decompose the set of somatic mutations into separate signature components.",{"name":119,"@type":110,"acceptedAnswer":120},"Why have hematological cancers been less studied compared with solid tumors?",{"text":121,"@type":113},"Many existing studies applied signature methods primarily to solid tumors, so extending these approaches to hematological cancers has produced limited results. The review addresses the challenges and summarizes the work done so far for hematologic malignancies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351198,1790156019,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","Official Publication of the Instituto Israelita de Ensino e Pesquisa Albert Einstein  \ne-ISSN: 2317-6385  \nHow to cite this article:  \nSartori FA, Pontes JV, Campregher PV, LaFramboise T. Mutational signatures in hematological malignancies. einstein (São Paulo) . 2026;24:eRW1961 .  \nAssociate Editor:  \nKenneth Gollob  \nHospital Israelita Albert Einstein, São Paulo, SP, Brazil  \nORCID: [https://orcid.org/0000-0003-4184-3867](https://orcid.org/0000-0003-4184-3867)  \nCorresponding Author:  \nThomas LaFramboise  \n10900 Euclid Avenue Cleveland Zip code: 44106-7078-Cleveland, Ohio, United States  \nPhone: (1) 216 773 1079  \n[E-mail: txl80@case.edu](E-mail: txl80@case.edu)  \nReceived on:  \nJune 24, 2025  \nAccepted on:  \nSep 10, 2025  \nCopyright the authors  \nThis content is licensed  \nunder a Creative Commons Attribution 4.0 International License.  \nREVIEW  \nMutational signatures in hematological malignancies  \nFelipe de Almeida Sartori1,2, João Vitor Paes Pontes2, Paulo Vidal Campregher2,3, Thomas LaFramboise1  \n1 Case Western Reserve University, Cleveland, Ohio, United States.  \n2 Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.  \n3 Genesis Genomics, São Paulo, SP, Brazil.  \nDOI: 10.31744/einstein_journal/2026RW1961  \n❚ ABSTRACT  \nThe set of somatic mutations present in a human tumor is a record of one or more mutational processes, each of which leaves distinct “signature” of mutation types. Mutation types can be classified in various ways, the most straightforward being the base change induced by a singlebase substitution (e.g., C>A, T>G, etc. ) . The advent of high-throughput DNA sequencing has facilitated the comprehensive, genome-wide assessment of mutation types in human tumors. This has spurred the development of methodology to tease apart the relative contribution of each mutational process by decomposing the set of all mutations into individual signatures. Many mutational signatures have known etiologies. Therefore, mutational signature inference can shed light on the causes of cancer and inform patient treatment. To date, most studies in this area have been performed on solid tumors; consequently, the application of existing methods to hematological cancers has yielded limited results. In this review, we provide an overview of the history and methodology behind mutational signature inference. Here, we present the challenges inherent in its application to hematological cancers and survey the work performed thus far. We highlight how recent research analyzing mutational signatures in normal blood cells can elucidate the beginning of a continuum of mutational processes, from normal hematopoiesis through mature hematological malignancy. Accurate characterization of mutational signatures in cancer development may aid in clinical diagnosis, prognosis, and treatment decisions.  \nKeywords: Mutational signatures; Hematological malignancy  \n❚ INTRODUCTION  \nSince the advent of high-throughput sequencing technologies, our understanding of the genetic underpinnings of human diseases has dramatically expanded.(1) Among the conditions most impacted by these advances is cancer, which is fundamentally driven by the accumulation of somatic mutations.(2) The ability to decode entire genomes has propelled research, providing unprecedented insights into the molecular basis of tumorigenesis and opening avenues for personalized medicine.(3)  \nA particularly intriguing discovery, dating back to the early 2000s, was the observation that mutations tend to occur in distinct patterns that are often associated with specific exposures. For instance, tumors arising in sunexposed skin commonly exhibit C>T and CC>TT transitions, reflecting DNA damage induced by ultraviolet (UV) light.(4) These recurring mutation patterns, now known as mutational signatures, suggest that a tumor’s mutational landscape carries a historical imprint of the biological processes and external agents that shaped its evolution. (3,5,6)  \neinstein (São Paulo) . 2026;24:1-1","cbCailmdesD84JNf","https://ap.wps.com/l/cbCailmdesD84JNf","pdf",717153,11,"English","# Abstract\n# Introduction\n## Somatic mutations and mutational signatures\n## Limitations of early studies\n## Whole-genome sequencing and signature discovery methods\n## Expanding beyond single base substitutions\n## Growth of the signature catalog","[{\"question\":\"What are mutational signatures and why are they important in cancer research?\",\"answer\":\"Mutational signatures are recurring patterns of mutation types shaped by specific biological processes or exposures. They help connect a tumor’s mutational landscape to mechanisms underlying its evolution.\"},{\"question\":\"How does high-throughput DNA sequencing support mutational signature inference?\",\"answer\":\"High-throughput sequencing enables comprehensive, genome-wide assessment of mutation types. This allows computational methods to decompose the set of somatic mutations into separate signature components.\"},{\"question\":\"Why have hematological cancers been less studied compared with solid tumors?\",\"answer\":\"Many existing studies applied signature methods primarily to solid tumors, so extending these approaches to hematological cancers has produced limited results. The review addresses the challenges and summarizes the work done so far for hematologic malignancies.\"}]","Mutational signatures in hematological malignancies | PDF",1790093036,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/edb558da71741da611125d785117b16c.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8e173b00bf0774bf368b0b385feeaa3.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a265ba51ec40ba1d3d81c667a58514d.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/827305b8f09b50db2dfc749fd999adf9.webp",980,1306]